« Volver al listado

CVE-2023-53734

Estado: AplazadaAlta (8.7)—

dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access.

CVSS

Probabilidad de explotación (EPSS)

EPSS (Exploit Prediction Scoring System, de FIRST) estima la probabilidad de que una vulnerabilidad sea explotada en 30 días. Complementa a CVSS (impacto) y a CISA KEV (explotación confirmada).

🎯 Técnicas ATT&CK

Cómo se explota esta vulnerabilidad y qué consigue el atacante, en el lenguaje de MITRE ATT&CK.

SQL injection remota sin autenticación (CWE-89, AV:N/PR:N). Acceso a datos sensibles (T1005) y potencial acceso administrativo (T1078) confirmado en descripción.

Inferido por nuestro agente de análisis a partir de la descripción oficial, el vector CVSS y la CWE, y comprobado por un supervisor. Puede contener errores.

🛡️ Mitigaciones ATT&CK que cubren estas técnicas

Privileged Account ManagementApplication Developer GuidanceActive Directory ConfigurationVulnerability ScanningUser TrainingUser Account Management

Tecnologías afectadas (1)

⚠ Inferidas por IA a partir de la descripción — NVD aún no ha analizado esta CVE; no son CPE verificados.

Dawa-pharma — Dawa-pharmaAI

CWE

Referencias

JSON original (NVD)

Mostrar
{
  "id": "CVE-2023-53734",
  "cveTags": [],
  "metrics": {
    "ssvcV203": [
      {
        "source": "134c704f-9b21-4f2e-91b3-4a467353bcc0",
        "ssvcData": {
          "id": "CVE-2023-53734",
          "role": "CISA Coordinator",
          "options": [
            {
              "exploitation": "poc"
            },
            {
              "automatable": "yes"
            },
            {
              "technicalImpact": "partial"
            }
          ],
          "version": "2.0.3",
          "timestamp": "2025-12-05T16:06:30.779874Z"
        }
      }
    ],
    "cvssMetricV40": [
      {
        "type": "Secondary",
        "source": "disclosure@vulncheck.com",
        "cvssData": {
          "Safety": "NOT_DEFINED",
          "version": "4.0",
          "Recovery": "NOT_DEFINED",
          "baseScore": 8.7,
          "Automatable": "NOT_DEFINED",
          "attackVector": "NETWORK",
          "baseSeverity": "HIGH",
          "valueDensity": "NOT_DEFINED",
          "vectorString": "CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X",
          "exploitMaturity": "NOT_DEFINED",
          "providerUrgency": "NOT_DEFINED",
          "userInteraction": "NONE",
          "attackComplexity": "LOW",
          "attackRequirements": "NONE",
          "privilegesRequired": "NONE",
          "subIntegrityImpact": "NONE",
          "vulnIntegrityImpact": "NONE",
          "integrityRequirement": "NOT_DEFINED",
          "modifiedAttackVector": "NOT_DEFINED",
          "subAvailabilityImpact": "NONE",
          "vulnAvailabilityImpact": "NONE",
          "availabilityRequirement": "NOT_DEFINED",
          "modifiedUserInteraction": "NOT_DEFINED",
          "modifiedAttackComplexity": "NOT_DEFINED",
          "subConfidentialityImpact": "NONE",
          "vulnConfidentialityImpact": "HIGH",
          "confidentialityRequirement": "NOT_DEFINED",
          "modifiedAttackRequirements": "NOT_DEFINED",
          "modifiedPrivilegesRequired": "NOT_DEFINED",
          "modifiedSubIntegrityImpact": "NOT_DEFINED",
          "modifiedVulnIntegrityImpact": "NOT_DEFINED",
          "vulnerabilityResponseEffort": "NOT_DEFINED",
          "modifiedSubAvailabilityImpact": "NOT_DEFINED",
          "modifiedVulnAvailabilityImpact": "NOT_DEFINED",
          "modifiedSubConfidentialityImpact": "NOT_DEFINED",
          "modifiedVulnConfidentialityImpact": "NOT_DEFINED"
        }
      }
    ]
  },
  "affected": [
    {
      "source": "disclosure@vulncheck.com",
      "affectedData": [
        {
          "vendor": "mayurik",
          "product": "dawa-pharma",
          "versions": [
            {
              "status": "affected",
              "version": "1.0-2022"
            }
          ],
          "defaultStatus": "unaffected"
        }
      ]
    }
  ],
  "published": "2025-12-04T21:16:06.980",
  "references": [
    {
      "url": "https://github.com/nu11secur1ty/CVE-nu11secur1ty/tree/main/vendors/mayuri_k/2022/dawa-pharma-1.0-2022",
      "source": "disclosure@vulncheck.com"
    },
    {
      "url": "https://www.exploit-db.com/exploits/51818",
      "source": "disclosure@vulncheck.com"
    },
    {
      "url": "https://www.mayurik.com/source-code/P0349/best-pharmacy-billing-software-free-download",
      "source": "disclosure@vulncheck.com"
    },
    {
      "url": "https://www.nu11secur1ty.com/",
      "source": "disclosure@vulncheck.com"
    },
    {
      "url": "https://www.vulncheck.com/advisories/dawa-pharma-10-sql-injection-via-email-parameter",
      "source": "disclosure@vulncheck.com"
    }
  ],
  "vulnStatus": "Deferred",
  "weaknesses": [
    {
      "type": "Secondary",
      "source": "disclosure@vulncheck.com",
      "description": [
        {
          "lang": "en",
          "value": "CWE-89"
        }
      ]
    }
  ],
  "descriptions": [
    {
      "lang": "en",
      "value": "dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access."
    }
  ],
  "lastModified": "2026-06-17T06:45:58.500",
  "sourceIdentifier": "disclosure@vulncheck.com"
}